Scientists decode the marker protein that can be used to ‘‘see’’ neuroinflammation

Inflammation is the sign that our body is defending itself against an aggression. But when this response escalates, for example in the brain, it can lead to serious neurological or psychiatric diseases.

Orphelia pushes boundaries with regulatory barriers for pediatric indications – Pharmaceutical Technology

Share this article Orphelia has developed Kizfizo as the first oral suspension of temozolomide to treat neuroblastoma. Credit: Nyaaka/Shutterstock.com Orphelia Pharma is taking action to

November 14, 2023

Study reveals link between illicit fentanyl use and HCV transmission among people who inject drugs

An international team of researchers from University of California San Diego and el Colegio de la Frontera Norte in Mexico have revealed a significant association

July 30, 2024

CHMP recommends against Mirati’s KRAS rival, in favor of Pfizer’s RSV vaccine, other drugs

The European Medicines Agency’s human medicines committee (CHMP) recommended against conditional authorization for Mirati’s KRAS G12C inhibitor Krazati in non-small cell lung cancer this week,

July 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.